Filter News
Area of Research
- Advanced Manufacturing (2)
- Biological Systems (1)
- Biology and Environment (29)
- Clean Energy (51)
- Computational Biology (1)
- Computational Engineering (1)
- Computer Science (2)
- Electricity and Smart Grid (2)
- Functional Materials for Energy (1)
- Fusion and Fission (7)
- Fusion Energy (1)
- Isotopes (4)
- Materials (30)
- Materials for Computing (5)
- National Security (32)
- Neutron Science (15)
- Nuclear Science and Technology (9)
- Quantum information Science (1)
- Supercomputing (56)
News Type
News Topics
- (-) Advanced Reactors (20)
- (-) Biomedical (46)
- (-) Composites (16)
- (-) Cybersecurity (32)
- (-) Frontier (40)
- (-) Grid (40)
- (-) Machine Learning (36)
- (-) Polymers (21)
- 3-D Printing/Advanced Manufacturing (87)
- Artificial Intelligence (77)
- Big Data (35)
- Bioenergy (75)
- Biology (80)
- Biotechnology (18)
- Buildings (33)
- Chemical Sciences (54)
- Clean Water (16)
- Climate Change (75)
- Computer Science (145)
- Coronavirus (34)
- Critical Materials (13)
- Decarbonization (67)
- Education (4)
- Element Discovery (1)
- Emergency (2)
- Energy Storage (72)
- Environment (147)
- Exascale Computing (37)
- Fossil Energy (5)
- Fusion (44)
- High-Performance Computing (75)
- Hydropower (5)
- Irradiation (1)
- Isotopes (47)
- ITER (4)
- Materials (108)
- Materials Science (98)
- Mathematics (7)
- Mercury (9)
- Microelectronics (3)
- Microscopy (37)
- Molten Salt (3)
- Nanotechnology (44)
- National Security (57)
- Net Zero (12)
- Neutron Science (101)
- Nuclear Energy (85)
- Partnerships (43)
- Physics (53)
- Quantum Computing (31)
- Quantum Science (58)
- Renewable Energy (2)
- Security (22)
- Simulation (42)
- Software (1)
- Space Exploration (15)
- Statistics (2)
- Summit (51)
- Sustainable Energy (78)
- Transformational Challenge Reactor (7)
- Transportation (57)
Media Contacts
Scientists have found new, unexpected behaviors when SARS-CoV-2 – the virus that causes COVID-19 – encounters drugs known as inhibitors, which bind to certain components of the virus and block its ability to reproduce.
Thirty-two Oak Ridge National Laboratory employees were named among teams recognized by former DOE Secretary Dan Brouillette with Secretary’s Honor Awards as he completed his term. Four teams received new awards that reflect DOE responses to the coronavirus pandemic.
Six scientists at the Department of Energy’s Oak Ridge National Laboratory were named Battelle Distinguished Inventors, in recognition of obtaining 14 or more patents during their careers at the lab.
The University of Texas at San Antonio (UTSA) has formally launched the Cybersecurity Manufacturing Innovation Institute (CyManII), a $111 million public-private partnership.
David Kropaczek, director of the Consortium for Advanced Simulation of Light Water Reactors, or CASL, at the Department of Energy’s Oak Ridge National Laboratory, has been named a fellow of the American Nuclear Society.
A multi-institutional team, led by a group of investigators at Oak Ridge National Laboratory, has been studying various SARS-CoV-2 protein targets, including the virus’s main protease. The feat has earned the team a finalist nomination for the Association of Computing Machinery, or ACM, Gordon Bell Special Prize for High Performance Computing-Based COVID-19 Research.
ORNL has added 10 virtual tours to its campus map, each with multiple views to show floor plans, rotating dollhouse views and 360-degree navigation. As a user travels through a map, pop-out informational windows deliver facts, videos, graphics and links to other related content.
NellOne Therapeutics has licensed a drug delivery system from the Department of Energy’s Oak Ridge National Laboratory that is designed to transport therapeutics directly to cells infected by SARS-CoV-2, the virus causing COVID-19.
Planning for a digitized, sustainable smart power grid is a challenge to which Suman Debnath is using not only his own applied mathematics expertise, but also the wider communal knowledge made possible by his revival of a local chapter of the IEEE professional society.
When Sandra Davern looks to the future, she sees individualized isotopes sent into the body with a specific target: cancer cells.